耳鼻咽喉科領域疾患に対する「イブナツク」使用経験

概要

論文の詳細を見る
Ibunac was administered for the purpose of examining the effects to the diseases in oto-rhino-pharyngo-laryngology, especially to inflammatory pains. 1. In tonsillitis, there was reduction of 0. 9 (actually for 1 day) in the exponent for pain disappearance and 1.3 days' reduction in the duration of a treatment by the administration of Ibunac for 2 days. 2. In acute and chronic otitis media, there was 0.5 days' reduction (actually for about 0.5 days) in the exponent for pain disappearance but there was almost no change with respect to the duration of a treatment by the administration for 1.3 days on an average. 3. In ear-and nose-ache, there was reduction of 0.7 (actually for a little less than one day) in the exponent for pain disappearance and 1. 7 days' reduction in the duration of a treatment by the administration for 2.0 days on an average. 4. As this medicine was administered to the patients with pains in particular as mentioned above, and the administration of Ibunac was discontinued after 1.3 to 2.0 days. This medicine has also a remarkable antifebrile function (No.38 & 42), therefore it may furthermore be possible to reduce a total duration of a treatment by 3 to 5 days' administration. 5. No side effect was observed at all.
耳鼻と臨床会の論文